Early pulmonary inflammation in infants with cystic fibrosis - PubMed
Early pulmonary inflammation in infants with cystic fibrosis
T Z Khan et al. Am J Respir Crit Care Med. 1995 Apr.
Abstract
The mechanisms underlying the initiation of lung disease and early respiratory morbidity in cystic fibrosis (CF) are poorly understood. By identifying infants with CF through a statewide neonatal screening program, we investigated whether airway inflammation was present in these infants, with the goal of furthering our understanding of the early events in this lung disease. Bronchoalveolar lavage fluid (BALF) from 16 infants with CF (mean age, 6 mo) and 11 disease control infants (mean age, 12 mo) was examined for the following inflammatory parameters: (1) neutrophil count; (2) activity of free neutrophil elastase; (3) elastase/alpha 1-antiprotease inhibitor complexes; and (4) the level of interleukin-8 (IL-8). We also quantified the spontaneous level of expression of IL-8 mRNA transcripts by airway macrophages. Each index of airway inflammation was increased in the BALF of infants with CF as compared with control infants. In addition, both the number of neutrophils and IL-8 levels were increased in infants with CF who had negative cultures (n = 7) for common bacterial CF-related pathogens, as well as for common respiratory viruses and fungi at the time of bronchoalveolar lavage (BAL). These findings suggest that airway inflammation is already present in infants with CF who are as young as 4 wks. Furthermore, although many different cell types (e.g., epithelial cells) may express IL-8, airway macrophages appear to be a source of this chemokine, and may thus play a prominent role in early neutrophil influx into the lung.
Comment in
-
Cystic fibrosis lung inflammation: early, sustained, and severe.
Cantin A. Cantin A. Am J Respir Crit Care Med. 1995 Apr;151(4):939-41. doi: 10.1164/ajrccm.151.4.7697269. Am J Respir Crit Care Med. 1995. PMID: 7697269 No abstract available.
Similar articles
-
Lower airway inflammation in infants with cystic fibrosis detected by newborn screening.
Armstrong DS, Hook SM, Jamsen KM, Nixon GM, Carzino R, Carlin JB, Robertson CF, Grimwood K. Armstrong DS, et al. Pediatr Pulmonol. 2005 Dec;40(6):500-10. doi: 10.1002/ppul.20294. Pediatr Pulmonol. 2005. PMID: 16208679
-
Meyer KC, Lewandoski JR, Zimmerman JJ, Nunley D, Calhoun WJ, Dopico GA. Meyer KC, et al. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):580-5. doi: 10.1164/ajrccm/144.3_Pt_1.580. Am Rev Respir Dis. 1991. PMID: 1892298
-
Association of Antibiotics, Airway Microbiome, and Inflammation in Infants with Cystic Fibrosis.
Pittman JE, Wylie KM, Akers K, Storch GA, Hatch J, Quante J, Frayman KB, Clarke N, Davis M, Stick SM, Hall GL, Montgomery G, Ranganathan S, Davis SD, Ferkol TW; Australian Respiratory Early Surveillance Team for Cystic Fibrosis. Pittman JE, et al. Ann Am Thorac Soc. 2017 Oct;14(10):1548-1555. doi: 10.1513/AnnalsATS.201702-121OC. Ann Am Thorac Soc. 2017. PMID: 28708417 Free PMC article.
-
Opportunities for the use of aerosolized alpha 1-antitrypsin for the treatment of cystic fibrosis.
Allen ED. Allen ED. Chest. 1996 Dec;110(6 Suppl):256S-260S. doi: 10.1378/chest.110.6_supplement.256s. Chest. 1996. PMID: 8989161 Review.
-
Birrer P. Birrer P. Respiration. 1995;62 Suppl 1:25-8. doi: 10.1159/000196490. Respiration. 1995. PMID: 7792437 Review.
Cited by
-
Modeling the response of a biofilm to silver-based antimicrobial.
Stine AE, Nassar D, Miller JK, Clemons CB, Wilber JP, Young GW, Yun YH, Cannon CL, Leid JG, Youngs WJ, Milsted A. Stine AE, et al. Math Biosci. 2013 Jul;244(1):29-39. doi: 10.1016/j.mbs.2013.04.006. Epub 2013 Apr 27. Math Biosci. 2013. PMID: 23628237 Free PMC article.
-
Animal Models of Cystic Fibrosis Pathology: Phenotypic Parallels and Divergences.
Lavelle GM, White MM, Browne N, McElvaney NG, Reeves EP. Lavelle GM, et al. Biomed Res Int. 2016;2016:5258727. doi: 10.1155/2016/5258727. Epub 2016 Jun 1. Biomed Res Int. 2016. PMID: 27340661 Free PMC article. Review.
-
Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis.
Gardner AI, Haq IJ, Simpson AJ, Becker KA, Gallagher J, Saint-Criq V, Verdon B, Mavin E, Trigg A, Gray MA, Koulman A, McDonnell MJ, Fisher AJ, Kramer EL, Clancy JP, Ward C, Schuchman EH, Gulbins E, Brodlie M. Gardner AI, et al. Am J Respir Crit Care Med. 2020 Oct 15;202(8):1133-1145. doi: 10.1164/rccm.202001-0180OC. Am J Respir Crit Care Med. 2020. PMID: 32569477 Free PMC article.
-
Azithromycin use in patients with cystic fibrosis.
Principi N, Blasi F, Esposito S. Principi N, et al. Eur J Clin Microbiol Infect Dis. 2015 Jun;34(6):1071-9. doi: 10.1007/s10096-015-2347-4. Epub 2015 Feb 17. Eur J Clin Microbiol Infect Dis. 2015. PMID: 25686729 Review.
-
An advanced stochastic model for mucociliary particle clearance in cystic fibrosis lungs.
Sturm R. Sturm R. J Thorac Dis. 2012 Feb;4(1):48-57. doi: 10.3978/j.issn.2072-1439.2011.09.09. J Thorac Dis. 2012. PMID: 22295167 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical